TABLE 5.
ID | Genotype | Allele-specific BDNF mRNA* | RPS18/10 mRNA* | BDNF mRNA/10,000 RPS18 mRNA | BDNF expression decrease (%) | BDNF expression, (Met, % of Val) | |||||||||
Condition -> | Pre-Val | Pre-Met | Post-Val | Post-Met | Pre | Post | Pre-Val | Pre-Met | Post-Val | Post-Met | Val | Met | Pre | Post | |
1 | Val/Val | 3.4 | 0 | 1.4 | 0 | 1,440 | 1,036 | 2.36 | 0 | 1.35 | 0 | −42.8 | |||
2 | Val/Val | 3.3 | 0 | 5 | 0 | 1,008 | 2,566 | 3.27 | 0 | 1.95 | 0 | −40.5 | |||
3 | Val/Met | 2.6 | 1.7 | 2.1 | 1.5 | 1,006 | 1,057 | 2.58 | 1.69 | 1.99 | 1.42 | −23.1 | −16.0 | 65.4 | 71.4 |
4 | Val/Val | 3.1 | 0 | 0.8 | 0 | 1,253 | 764 | 2.47 | 0 | 1.05 | 0 | −57.7 | |||
5 | Val/Met | 1.7 | 1.3 | 1.6 | 1.4 | 1,453 | 1,994 | 1.17 | 0.89 | 0.80 | 0.70 | −31.4 | −21.5 | 76.5 | 87.5 |
6 | Val/Val | 7.9 | 0 | 3.4 | 0 | 2,322 | 2,024 | 3.40 | 0 | 1.68 | 0 | −50.6 | |||
7 | Val/Val | 2.2 | 0 | 3.3 | 0 | 1,088 | 2,516 | 2.02 | 0 | 1.31 | 0 | −35.1 | |||
8 | Val/Val | 6.5 | 0 | 3.1 | 0 | 1,203 | 1,017 | 5.40 | 0 | 3.05 | 0 | −43.6 | |||
9 | Val/Val | 7.5 | 0 | 5.7 | 0 | 2,361 | 2,452 | 3.18 | 0 | 2.32 | 0 | −26.8 | |||
10 | Val/Val | 6.4 | 0 | 5 | 0 | 1,620 | 1,924 | 3.95 | 0 | 2.60 | 0 | −34.2 | |||
11 | Met/Met | 0 | 6.1 | 0 | 8.8 | 1,454 | 3,200 | 0 | 4.20 | 0 | 2.75 | 0 | −34.5 | ||
12 | Val/Met | 3.8 | 3.1 | 2.7 | 2.4 | 1,507 | 2,396 | 2.52 | 2.06 | 1.13 | 1.00 | −55,3 | −51.3 | 81.6 | 88.9 |
13 | Val/Val | 4.1 | 0 | 2.9 | 0 | 2,275 | 3,095 | 1.80 | 0 | 0.94 | 0 | −48,0 | |||
Mean | −38.3 ± 12.5 | 78.5 ± 9.2 |
*Expression values are disposed in (copies/μl of reaction mixture), 1 μl of reaction mixture corresponds to 0.625–1.25 mg of muscle tissue. Pre-Val, BDNF Val66-allele expression values in rest; post-Val, Val66-allele expression values after VO2max test; pre-Met, BDNF Met66-allele expression values in rest; post-Met, Met66-allele expression values after VO2max test; RPS18, ribosomal protein S18 gene expression values, pre- and post.